schliessen

Filtern

 

Bibliotheken

N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis

Prospective observational studies have shown inconsistent associations of dietary or circulating n-3 long-chain polyunsaturated fatty acids (LCPUFA) with risk of all-cause mortality. A meta-analysis was performed to evaluate the associations. Potentially eligible studies were identified by searching... Full description

Journal Title: Sci Rep 2016, Vol.6(1), pp.28165-28165
Main Author: Chen, Guo-Chong
Other Authors: Yang, Jing , Eggersdorfer, Manfred , Zhang, Weiguo , Qin, Li-Qiang
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 2045-2322 ; DOI: 10.1038/srep28165
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: palgrave_j10.1038/srep28165
title: N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis
format: Article
creator:
  • Chen, Guo-Chong
  • Yang, Jing
  • Eggersdorfer, Manfred
  • Zhang, Weiguo
  • Qin, Li-Qiang
subjects:
  • Article
ispartof: Sci Rep, 2016, Vol.6(1), pp.28165-28165
description: Prospective observational studies have shown inconsistent associations of dietary or circulating n-3 long-chain polyunsaturated fatty acids (LCPUFA) with risk of all-cause mortality. A meta-analysis was performed to evaluate the associations. Potentially eligible studies were identified by searching PubMed and EMBASE databases. The summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using the random-effects model. Eleven prospective studies involving 371 965 participants from general populations and 31 185 death events were included. The summary RR of all-cause mortality for high-versus-low n-3 LCPUFA intake was 0.91 (95% CI: 0.84–0.98). The summary RR for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake was 0.83 (95% CI: 0.75–0.92) and 0.81 (95% CI: 0.74–0.95), respectively. In the dose-response analysis, each 0.3 g/d increment in n-3 LCPUFA intake was associated with 6% lower risk of all-cause mortality (RR = 0.94, 95% CI: 0.89–0.99); and each 1% increment in the proportions of circulating EPA and DHA in total fatty acids in blood was associated with 20% (RR = 0.80, 95% CI: 0.65–0.98) and 21% (RR = 0.79, 95% CI: 0.63–0.99) decreased risk of all-cause mortality, respectively. Moderate to high heterogeneity was observed across our anlayses. Our findings suggest that both dietary and circulating LCPUFA are inversely associated with all-cause mortality.
language: eng
source:
identifier: ISSN: 2045-2322 ; DOI: 10.1038/srep28165
fulltext: fulltext
issn:
  • 2045-2322
  • 20452322
url: Link


@attributes
ID1598303300
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1038/srep28165
sourceidpalgrave_j
recordidTN_palgrave_j10.1038/srep28165
sourcesystemPC
pqid1797870401
display
typearticle
titleN-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis
creatorChen, Guo-Chong ; Yang, Jing ; Eggersdorfer, Manfred ; Zhang, Weiguo ; Qin, Li-Qiang
ispartofSci Rep, 2016, Vol.6(1), pp.28165-28165
identifierISSN: 2045-2322 ; DOI: 10.1038/srep28165
descriptionProspective observational studies have shown inconsistent associations of dietary or circulating n-3 long-chain polyunsaturated fatty acids (LCPUFA) with risk of all-cause mortality. A meta-analysis was performed to evaluate the associations. Potentially eligible studies were identified by searching PubMed and EMBASE databases. The summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using the random-effects model. Eleven prospective studies involving 371 965 participants from general populations and 31 185 death events were included. The summary RR of all-cause mortality for high-versus-low n-3 LCPUFA intake was 0.91 (95% CI: 0.84–0.98). The summary RR for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake was 0.83 (95% CI: 0.75–0.92) and 0.81 (95% CI: 0.74–0.95), respectively. In the dose-response analysis, each 0.3 g/d increment in n-3 LCPUFA intake was associated with 6% lower risk of all-cause mortality (RR = 0.94, 95% CI: 0.89–0.99); and each 1% increment in the proportions of circulating EPA and DHA in total fatty acids in blood was associated with 20% (RR = 0.80, 95% CI: 0.65–0.98) and 21% (RR = 0.79, 95% CI: 0.63–0.99) decreased risk of all-cause mortality, respectively. Moderate to high heterogeneity was observed across our anlayses. Our findings suggest that both dietary and circulating LCPUFA are inversely associated with all-cause mortality.
languageeng
source
subjectArticle;
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Chen, Guo-Chong
1Yang, Jing
2Eggersdorfer, Manfred
3Zhang, Weiguo
4Qin, Li-Qiang
titleN-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis
descriptionProspective observational studies have shown inconsistent associations of dietary or circulating n-3 long-chain polyunsaturated fatty acids (LCPUFA) with risk of all-cause mortality. A meta-analysis was performed to evaluate the associations. Potentially eligible studies were identified by searching PubMed and EMBASE databases. The summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using the random-effects model. Eleven prospective studies involving 371 965 participants from general populations and 31 185 death events were included. The summary RR of all-cause mortality for high-versus-low n-3 LCPUFA intake was 0.91 (95% CI: 0.84–0.98). The summary RR for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake was 0.83 (95% CI: 0.75–0.92) and 0.81 (95% CI: 0.74–0.95), respectively. In the dose-response analysis, each 0.3 g/d increment in n-3 LCPUFA intake was associated with 6% lower risk of all-cause mortality (RR = 0.94, 95% CI: 0.89–0.99); and each 1% increment in the proportions of circulating EPA and DHA in total fatty acids in blood was associated with 20% (RR = 0.80, 95% CI: 0.65–0.98) and 21% (RR = 0.79, 95% CI: 0.63–0.99) decreased risk of all-cause mortality, respectively. Moderate to high heterogeneity was observed across our anlayses. Our findings suggest that both dietary and circulating LCPUFA are inversely associated with all-cause mortality.
general
0English
110.1038/srep28165
2Palgrave Macmillan Journals
sourceidpalgrave_j
recordidpalgrave_j10.1038/srep28165
issn
02045-2322
120452322
rsrctypearticle
creationdate2016
addtitleSci Rep
searchscopepalgrave_j
scopepalgrave_j
lsr30VSR-Enriched:[pqid, date, pages, subject]
sort
titleN-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis
authorChen, Guo-Chong ; Yang, Jing ; Eggersdorfer, Manfred ; Zhang, Weiguo ; Qin, Li-Qiang
facets
frbrgroupid6428979282355431898
frbrtype5
newrecords20180122
languageeng
creationdate2016
collectionPalgrave Macmillan Journals
prefilterarticles
rsrctypearticles
creatorcontrib
0Chen, Guo-Chong
1Yang, Jing
2Eggersdorfer, Manfred
3Zhang, Weiguo
4Qin, Li-Qiang
jtitleSci Rep
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Chen
1Yang
2Eggersdorfer
3Zhang
4Qin
aufirst
0Guo-Chong
1Jing
2Manfred
3Weiguo
4Li-Qiang
au
0Chen, Guo-Chong
1Yang, Jing
2Eggersdorfer, Manfred
3Zhang, Weiguo
4Qin, Li-Qiang
atitleN-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis
jtitleSci Rep
risdate20169
volume6
issue1
spage28165
epage28165
issn2045-2322
formatjournal
genrearticle
ristypeJOUR
abstractProspective observational studies have shown inconsistent associations of dietary or circulating n-3 long-chain polyunsaturated fatty acids (LCPUFA) with risk of all-cause mortality. A meta-analysis was performed to evaluate the associations. Potentially eligible studies were identified by searching PubMed and EMBASE databases. The summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using the random-effects model. Eleven prospective studies involving 371 965 participants from general populations and 31 185 death events were included. The summary RR of all-cause mortality for high-versus-low n-3 LCPUFA intake was 0.91 (95% CI: 0.84–0.98). The summary RR for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake was 0.83 (95% CI: 0.75–0.92) and 0.81 (95% CI: 0.74–0.95), respectively. In the dose-response analysis, each 0.3 g/d increment in n-3 LCPUFA intake was associated with 6% lower risk of all-cause mortality (RR = 0.94, 95% CI: 0.89–0.99); and each 1% increment in the proportions of circulating EPA and DHA in total fatty acids in blood was associated with 20% (RR = 0.80, 95% CI: 0.65–0.98) and 21% (RR = 0.79, 95% CI: 0.63–0.99) decreased risk of all-cause mortality, respectively. Moderate to high heterogeneity was observed across our anlayses. Our findings suggest that both dietary and circulating LCPUFA are inversely associated with all-cause mortality.
pubNature Publishing Group UK
doi10.1038/srep28165
pages28165
date2016-06-16